Tim Freeman - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Tim Freeman

Tim Freeman Pharmtech contributing editor and EAB member

Tim Freeman
Managing Director, Freeman Technology



Tim Freeman is Managing Director of powder characterization company Freeman Technology for whom he has worked since the mid 1990s. He was instrumental in the original design and continuing development of the FT4 Powder Rheometer and in the past decade has co-led the team that has grown Freeman Technology from a start-up business to the global organization of today. Through his work with various professional bodies and involvement in industry initiatives Tim is an established contributor to wider developments in powder processing.

Tim has a degree in Mechatronics from the University of Sussex in the UK. He has extensive experience in application and method development for the FT4 Powder Rheometer and works closely with customers worldwide across the powder processing industries. Tim is a mentor on a number of project groups for the Engineering Research Center for Structured Organic Particulate Systems in the US. He is a frequent contributor to industry conferences, instructs on training courses for powder processing and writes regularly for a variety of publications.

In the pharmaceutical field Tim is a past Chair of the American Association of Pharmaceutical Scientists (AAPS) Process Analytical Technology Focus Group and is a member of the Editorial Advisory Boards of Life Science Leader magazine (Jameson Publishing Inc. http://www.lifescienceleader.com) and Pharmaceutical Technology (Advanstar Communications Inc. www.pharmtech.com)


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here